Managing Upper and Lower Airway Diseases: The Role of Epithelial-Driven Inflammation is organized by Healio, National Jewish Health (NJH).
Activity Release Date: June 30, 2025
Activity Expiration Date: June 30, 2026
Description:
Epithelial-driven inflammatory airway diseases including CRSwNP, asthma, COPD, and allergic rhinitis are characterized by their heterogeneous nature and complex pathophysiology. Traditionally, these upper and lower airway diseases have been managed independently, often leading to suboptimal patient care.
In this program, experts in pulmonology, allergy and otolaryngology will explore the complexities of epithelial-driven inflammatory airway diseases and how epithelial cytokines play a role in shaping disease severity. The expert panel will discuss the importance of managing upper and lower inflammatory airway diseases together and how the evolving treatment landscape may affect clinical practice. Clinical case scenarios will illustrate strategies for personalizing treatment plans to improve outcomes for patients with comorbid upper and lower airway diseases.
Learning Objectives:
Credits:
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation:
National Jewish Health designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved